Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation

Transplantation

Volumn 92, Issue 6, 2011, Pages 690-696

  Lee, Sang Oh ^a,b   Brown, Robert A ^a   Kang, Seung H ^a   Abdel Massih, Rima C ^a   Razonable, Raymund R ^a  

^a MAYO CLINIC   (United States)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Infection; Liver transplantation; Mortality; Polymorphism; Toll like receptor

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AZATHIOPRINE; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALGANCICLOVIR; VANCOMYCIN;

ABDOMINAL ABSCESS; ADULT; ALCOHOL LIVER DISEASE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BILIARY TRACT INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GENETIC RISK; GRAFT RECIPIENT; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; KLEBSIELLA PNEUMONIAE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; PERITONITIS; PNEUMOCYSTOSIS; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL INFECTION; SURGICAL RISK; TLR4 GENE; ULCERATIVE COLITIS; URINARY TRACT INFECTION;

ADULT; BACTERIAL INFECTIONS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GRAM-NEGATIVE BACTERIA; HOMOZYGOTE; HUMANS; IMMUNE SYSTEM; LIPOPOLYSACCHARIDES; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; TOLL-LIKE RECEPTOR 4;

EID: 80052689729     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822b589f     Document Type: Article

References (19)

1. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003; 16: 379.
2. Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186: 1522.
3. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187.
4. Ben-Ali M, Barbouche MR, Bousnina S, et al. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625.
5. Montes AH, Asensi V, Alvarez V, et al. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for gram-negative and haematogenous osteomyelitis. Clin Exp Immunol 2006; 143: 404.
6. Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219.
7. SchroderNW,Diterich I, Zinke A, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005; 175: 2534.
8. Tal G, Mandelberg A, Dalal I, et al. Association between common Tolllike receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189: 2057.
9. Eid AJ, Brown RA, Paya CV, et al. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007; 84: 511.
10. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749.
11. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085.
12. Bone RC. Gram-negative sepsis. Background, clinical features, and intervention. Chest 1991; 100: 802.
13. Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162: 1028.
14. Jessen KM, Lindboe SB, Petersen AL, et al. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 2007; 7: 108.
15. Mensah NY, Peterlongo P, Steinherz P, et al. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant 2009; 15: 1130.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644.
17. Kim SH, Park WB, Lee KD, et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003; 37: 794.
18. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309.